Hydromorphone Hydrochloride Injection
Brand names: Dilaudid, Hydromorphone Hydrochloride
Category: Analgesia/Addiction
Unavailable 9Limited 3Available 14
FDA status: Current · Last FDA update: Sep 22, 2026 · First posted: Oct 31, 2017 (in shortage 8 years 11 months) · 4 manufacturers, 26 listed presentations
As of Sep 22, 2026, the FDA lists Hydromorphone Hydrochloride Injection as currently in shortage. Of 26 manufacturer presentations, 9 Unavailable, 3 Limited, 14 Available.
Ask your pharmacist: which of the 4 manufacturers below can they order right now, and whether a different strength or form of Hydromorphone Hydrochloride Injection is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.
| Presentation & package NDC | Manufacturer | Availability | FDA note |
|---|---|---|---|
| Dilaudid, Injection, .2 mg/1 mL (NDC 76045-121-11) NDC 76045-121-11 |
Fresenius Kabi USA, LLC | Unavailable | Next release November 2026. Check wholesalers for inventory. |
| Dilaudid, Injection, 1 mg/1 mL (NDC 76045-009-11) NDC 76045-009-11 |
Fresenius Kabi USA, LLC | Unavailable | Next release October 2026. Check wholesalers for inventory. |
| Hydromorphone Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-852-25) NDC 63323-852-25 |
Fresenius Kabi USA, LLC | Unavailable | Next release October 2026. Check wholesalers for inventory. |
| Dilaudid, Injection, 1 mg/1 mL (NDC 76045-009-06) NDC 76045-009-06 |
Fresenius Kabi USA, LLC | Unavailable | Next release September 2026. Check wholesalers for inventory. |
| Hydromorphone Hydrochloride, Injection, 1 mg/1 mL (NDC 0409-1283-37) NDC 0409-1283-37 |
Hospira, Inc., a Pfizer Company | Unavailable | Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay |
| Hydromorphone Hydrochloride, Injection, 1 mg/1 mL Syringes (NDC 0409-1283-31) NDC 0409-1283-31 |
Hospira, Inc., a Pfizer Company | Available | - |
| Dilaudid, Injection, 2 mg/1 mL (NDC 76045-010-11) NDC 76045-010-11 |
Fresenius Kabi USA, LLC | Unavailable | Next release not available at this time. Check wholesalers for inventory. |
| Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 63323-853-25) NDC 63323-853-25 |
Fresenius Kabi USA, LLC | Unavailable | Next release September 2026. Check wholesalers for inventory. |
| Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0641-6254-01) NDC 0641-6254-01 |
Hikma Pharmaceuticals USA, Inc. | Unavailable | Product temporarily on backorder. Additional lots will be available in the September 2026 timeframe. |
| Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0409-1312-36) NDC 0409-1312-36 |
Hospira, Inc., a Pfizer Company | Limited | Limited Supply Available. Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay |
| Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0641-0121-25) NDC 0641-0121-25 |
Hikma Pharmaceuticals USA, Inc. | Available | Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. |
| Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0409-3365-10) NDC 0409-3365-10 |
Hospira, Inc., a Pfizer Company | Available | - |
| Hydromorphone Hydrochloride, Injection, 2 mg/1 mL Syringes (NDC 0409-1312-30) NDC 0409-1312-30 |
Hospira, Inc., a Pfizer Company | Available | - |
| Hydromorphone Hydrochloride, Injection, 4 mg/1 mL (NDC 63323-854-10) NDC 63323-854-10 |
Fresenius Kabi USA, LLC | Available | Check wholesalers for inventory |
| Hydromorphone Hydrochloride, Injection, 4 mg/1 mL Syringes (NDC 0409-1304-31) NDC 0409-1304-31 |
Hospira, Inc., a Pfizer Company | Available | - |
| Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0113-03) NDC 0703-0113-03 |
Teva Pharmaceuticals USA, Inc. | Limited | Estimated recovery: TBD |
| Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-15) NDC 63323-851-15 |
Fresenius Kabi USA, LLC | Available | Check wholesaler for inventory |
| Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-10) NDC 63323-851-10 |
Fresenius Kabi USA, LLC | Available | Check wholesalers for inventory |
| Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-50) NDC 63323-851-50 |
Fresenius Kabi USA, LLC | Available | Check wholesalers for inventory |
| Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0409-2634-01) NDC 0409-2634-01 |
Hospira, Inc., a Pfizer Company | Available | - |
| Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0110-03) NDC 0703-0110-03 |
Teva Pharmaceuticals USA, Inc. | Available | - |
| Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0018-01) NDC 0703-0018-01 |
Teva Pharmaceuticals USA, Inc. | Available | - |
| Hydromorphone Hydrochloride, Injection, 0.25 mg/ 0.5 mL NexJect™ Single-dose Syringe Luer Lock (no needle) (NDC 0409-1805-01) NDC 0409-1805-01 |
Hospira, Inc., a Pfizer Company | Unavailable | Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay |
| Hydromorphone Hydrochloride, Injection, 0.5 mg/0.5 mL NexJect™ Single-dose Syringe Luer Lock (no needle) (NDC 0409-4264-01) NDC 0409-4264-01 |
Hospira, Inc., a Pfizer Company | Limited | Limited Supply Available. Next Delivery: September 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay |
| Hydromorphone Hydrochloride, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-2634-05) NDC 0409-2634-05 |
Hospira, Inc., a Pfizer Company | Available | - |
| Hydromorphone Hydrochloride, Injection, 500 mg/50 mL (10 mg/mL) (NDC 0409-2634-50) NDC 0409-2634-50 |
Hospira, Inc., a Pfizer Company | Available | - |
Related medications in shortage
Other Analgesia/Addiction medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.
Change log
No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Cite this: “FDA drug-shortage status for Hydromorphone Hydrochloride Injection (FDA data as of Sep 22, 2026). Shortage Watch, openFDA.”
Get an email when this record changes
One email, only when the FDA changes something for Hydromorphone Hydrochloride Injection. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.
Check your inbox - click the confirmation link to activate
alerts for Hydromorphone Hydrochloride Injection.
Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.
Embed a live status badge: /badge/hydromorphone-hydrochloride-injection.svg
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).